Neurocrine Biosciences Inc (NAS:NBIX)
$ 142 3.52 (2.54%) Market Cap: 14.29 Bil Enterprise Value: 13.59 Bil PE Ratio: 39.12 PB Ratio: 5.99 GF Score: 89/100

Neurocrine Biosciences Inc at Jefferies Healthcare Conference Transcript

Jun 06, 2019 / 02:30PM GMT
Release Date Price: $80.83 (-1.25%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Okay. Let's get started. My name is Biren Amin. I'm one of the biotech analysts here at Jefferies. I'd like to welcome our next company. We have Neurocrine Biosciences, their CEO, Kevin Gorman; CFO, Matt Abernethy. This is going to be a fireside chat.

So I guess, Matt, do you want to -- before we get started with Q&A, I don't know if you want to read, I guess -- or talk about forward-looking statements just so we cover that aspect.

Matthew C. Abernethy
Neurocrine Biosciences, Inc. - CFO

Yes. Kevin can kick this off.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

Yes. So we will be making forward-looking statements, so I direct you to our recent SEC filings for all the risks associated with the industry and with our company.

Questions & Answers

Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Great. So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot